Healthcare & Life Sciences
EPICS Therapeutics
Belgiumwww.epicstherapeutics.com/
EPICS Therapeutics is a Healthcare & Life Sciences startup based in Belgium, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About EPICS Therapeutics
EPICS Therapeutics is a startup based in Belgium. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
EPICS Therapeutics is a clinical-stage biotechnology company developing small-molecule inhibitors targeting RNA epigenetic regulation, with its lead program EP102, a METTL3 inhibitor, currently in clinical evaluation for solid tumors including NSCLC, pancreatic, ovarian, and colorectal cancers.
Explore EPICS Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.